Kamada (KMDA) EBITDA Margin (2012 - 2026)
Kamada's (KMDA) quarterly EBITDA Margin came in at 25.65% in Q1 2026, down 66.0% YoY from 75.44% in Q1 2025, and up 46.71% on a QoQ basis from 17.48% in Q4 2025.
Kamada (KMDA) EBITDA Margin (2012 - 2026) Analysis & Trends
Kamada (KMDA) has 15 years of EBITDA Margin data on file, last reported at 25.65% in Q1 2026.
- Quarterly EBITDA Margin fell 66.0% year-over-year to 25.65% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 42.24% (up 4216.0% YoY) and the FY2025 annual result came in at 23.27%, up 207.0% from the prior year.
- EBITDA Margin rose to 25.65% in Q1 2026, from 17.48% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 42.3% in Q2 2025 to a low of 9.72% in Q2 2022.
- A 5-year average of 15.54% and a median of 17.45% in 2023 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2022 — EBITDA Margin tumbled 1404 bps — and 2025, when it soared 4228 bps.
- Tracing KMDA's EBITDA Margin over 5 years: stood at 15.95% in 2022, then rose by 9 bps to 17.45% in 2023, then rose by 29 bps to 22.45% in 2024, then dropped by 22 bps to 17.48% in 2025, then jumped by 47 bps to 25.65% in 2026.
- The last three EBITDA Margin figures came in at 25.65% (Q1 2026), 17.48% (Q4 2025), and 26.21% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Kamada | 466.36 Mn | 436.89 Mn | 22.47 Mn | 17.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.32% |
| Mar 31, 2026 | 25.65% |
| Dec 31, 2025 | 17.48% |
| Sep 30, 2025 | 26.21% |
| Jun 30, 2025 | 42.30% |
| Mar 31, 2025 | 26.31% |
| Dec 31, 2024 | 22.45% |
| Sep 30, 2024 | 20.99% |
| Jun 30, 2024 | 0.01% |
| Mar 31, 2024 | 10.70% |
| Dec 31, 2023 | 17.45% |
| Sep 30, 2023 | 20.72% |
| Jun 30, 2023 | 7.03% |
| Mar 31, 2023 | 0.94% |
| Dec 31, 2022 | 15.95% |
| Sep 30, 2022 | 7.95% |
| Jun 30, 2022 | -9.72% |
| Mar 31, 2022 | 11.70% |
| Dec 31, 2021 | 4.07% |
| Sep 30, 2021 | -3.49% |